Abstract
Nucleic Acid TherapeuticsVol. 21, No. 6 PerspectiveThe Development of RNA Interference TherapeuticsJohn J. RossiJohn J. RossiSearch for more papers by this authorPublished Online:23 Dec 2011https://doi.org/10.1089/nat.2011.1503AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"The Development of RNA Interference Therapeutics." , 21(6), pp. 371–372FiguresReferencesRelatedDetailsCited byMethods for Assembling B-Cell Lymphoma Specific and Internalizing Aptamer–siRNA Nanoparticles Via the Sticky BridgeTumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA15 September 2014 | Nucleic Acids Research, Vol. 42, No. 18Nanodelivery Systems for Nucleic Acid Therapeutics in Drug Resistant Tumors1 April 2014 | Molecular Pharmaceutics, Vol. 11, No. 8Ion exchange liquid chromatography method for the direct determination of small ribonucleic acidsAnalytica Chimica Acta, Vol. 799Something Old, Something New Bruce Sullenger23 December 2011 | Nucleic Acid Therapeutics, Vol. 21, No. 6 Volume 21Issue 6Dec 2011 InformationCopyright 2011, Mary Ann Liebert, Inc.To cite this article:John J. Rossi.The Development of RNA Interference Therapeutics.Nucleic Acid Therapeutics.Dec 2011.371-372.http://doi.org/10.1089/nat.2011.1503Published in Volume: 21 Issue 6: December 23, 2011PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
